Zimmer’s CPT Hip System: Why Fracture Risks Are Forcing a Phase-Out.

By

Zimmer pulls hip implant off the market due to fracture risk (MedTechDive)The company plans to phase out use of its CPT Hip System by December, but the FDA is still concerned about implants in new patients.
Dive Brief:

Zimmer Biomet will phase out sales of its CPT Hip System by December due to concerns about the risk of thigh bone fractures, the Food and Drug Administration said in a Tuesday notice. 
Despite plans to pull the device, the FDA said it is still concerned about the hip system being implanted in new patients, and it is “working with the manufacturer to address these concerns.” 
E...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.